Last updated: Oct 30, 2026, 12:00 AM

MoonLake Immunotherapeutics Exchange (NASDAQ, USD)

MLTX

11.78
-0.04 (-0.34%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
24.84%
3 year return (CAGR)
-40.58%
5 year return (CAGR)
3.38%
10 year return (CAGR)
-
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
1.01B
Price/Sales
-
Ent value
672.96M
Price/Book
2.35
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open11.82
Daily high12.45
Daily low11.66
Daily Volume1.51M
All-time high63.86
1y analyst estimate28.54
Beta1.03
EPS (TTM)-3.57
Dividend per share0.00
Ex-div date-
Next earnings date26 Feb 2026

Ready to capitalize on MoonLake Immunotherapeutics's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
MLTXS&P500
Current price drop from All-time high-81.55%-3.00%
Highest price drop-90.22%-56.47%
Date of highest drop29 Sep 20259 Mar 2009
Avg drop from high-32.35%-10.65%
Avg time to new high28 days12 days
Max time to new high679 days1805 days